Evaluation of brainstem involvement in multiple sclerosis

Expert Review of Neurotherapeutics

Volumn 13, Issue 3, 2013, Pages 299-311

  Habek, Mario ^a,b  

^a KBC Zagreb   (Croatia)

^b UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

autonomic nervous system; brainstem; evoked potentials; MRI; multiple sclerosis; sleep; symptoms; trigeminal somatosensory evoked potentials; vestibular myogenic evoked potentials

Indexed keywords

AUTONOMIC DYSFUNCTION; AUTONOMIC NERVOUS SYSTEM; AUTONOMIC NEUROPATHY; BRAIN ELECTROPHYSIOLOGY; BRAIN STEM; BRAIN STEM INJURY; DIPLOPIA; EVOKED SOMATOSENSORY RESPONSE; HUMAN; MULTIPLE SCLEROSIS; NEUROPHYSIOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; REVIEW; SLEEP; TRIGEMINAL NERVE; VERTIGO; VESTIBULAR EVOKED MYOGENIC POTENTIAL;

AUTONOMIC NERVOUS SYSTEM DISEASES; BRAIN STEM; EVOKED POTENTIALS; HUMANS; MAGNETIC RESONANCE IMAGING; MULTIPLE SCLEROSIS; SLEEP DISORDERS;

EID: 84874617278     PISSN: 14737175     EISSN: 17448360     Source Type: Journal    
DOI: 10.1586/ern.13.18     Document Type: Review

References (104)

1. Confavreux C, Vukusic S. Natural history of multiple sclerosis: a unifying concept. Brain 129(Pt 3), 606-616 (2006).
2. Miller DH, Chard DT, Ciccarelli O. Clinically isolated syndromes. Lancet Neurol. 11(2), 157-169 (2012).
3. Fisniku LK, Brex PA, Altmann DR et al. Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis. Brain 131(Pt 3), 808-817 (2008).
4. Tintore M, Rovira A, Arrambide G et al. Brainstem lesions in clinically isolated syndromes. Neurology 75(21), 1933-1938 (2010).
5. Filippi M, Horsfield MA, Morrissey SP et al. Quantitative brain MRI lesion load predicts the course of clinically isolated syndromes suggestive of multiple sclerosis. Neurology 44(4), 635-641 (1994).
6. Sailer M, O'Riordan JI, Thompson AJ et al. Quantitative MRI in patients with clinically isolated syndromes suggestive of demyelination. Neurology 52(3), 599-606 (1999).
7. Minneboo A, Barkhof F, Polman CH, Uitdehaag BM, Knol DL, Castelijns JA. Infratentorial lesions predict long-term disability in patients with initial findings suggestive of multiple sclerosis. Arch. Neurol. 61(2), 217-221 (2004).
8. Sastre-Garriga J, Tintoré M, Nos C et al. Clinical features of CIS of the brainstem/cerebellum of the kind seen in MS. J. Neurol. 257(5), 742-746 (2010).
9. Gabelic T, Radmilovic M, Posavec V et al. Differences in oligoclonal bands and visual evoked potentials in patients with radiologically and clinically isolated syndrome. Acta Neurol. Belg. doi:10.1007/s13760-012-0106-1 (2012) (Epub ahead of print).
10. Nakashima I, Fujihara K, Okita N, Takase S, Itoyama Y. Clinical and MRI study of brain stem and cerebellar involvement in Japanese patients with multiple sclerosis. J. Neurol. Neurosurg. Psychiatr. 67(2), 153-157 (1999).
11. Eriksson M, Ben-Menachem E, Andersen O. Epileptic seizures, cranial neuralgias and paroxysmal symptoms in remitting and progressive multiple sclerosis. Mult. Scler. 8(6), 495-499 (2002).
12. Pula JH, Brock K, Kattah JC. Clinical course of patients with ophthalmoplegia caused by radiographically detectable brainstem demyelination occurring as a clinically isolated demyelinating syndrome. J. Neuroophthalmol. 31(3), 234-238 (2011).
13. Zadro I, Barun B, Habek M, Brinar VV. Isolated cranial nerve palsies in multiple sclerosis. Clin. Neurol. Neurosurg. 110(9), 886-888 (2008).
14. Gass A, Kitchen N, MacManus DG, Moseley IF, Hennerici MG, Miller DH. Trigeminal neuralgia in patients with multiple sclerosis: lesion localization with magnetic resonance imaging. Neurology 49(4), 1142-1144 (1997).
15. Herrera WG. Vestibular and other balance disorders in multiple sclerosis. Differential diagnosis of disequilibrium and topognostic localization. Neurol. Clin. 8(2), 407-420 (1990).
16. Williams NP, Roland PS, Yellin W. Vestibular evaluation in patients with early multiple sclerosis. Am. J. Otol. 18(1), 93-100 (1997).
17. Degirmenci E, Bir LS, Ardic FN. Clinical and electronystagmographical evaluation of vestibular symptoms in relapsing remitting multiple sclerosis. Neurol. Res. 32(9), 986-991 (2010).
18. Frohman EM, Kramer PD, Dewey RB, Kramer L, Frohman TC. Benign paroxysmal positioning vertigo in multiple sclerosis: diagnosis, pathophysiology and therapeutic techniques. Mult. Scler. 9(3), 250-255 (2003).
19. Sastre-Garriga J, Tintoré M, Rovira A et al. Conversion to multiple sclerosis after a clinically isolated syndrome of the brainstem: cranial magnetic resonance imaging, cerebrospinal fluid and neurophysiological findings. Mult. Scler. 9(1), 39-43 (2003).
20. Feys P, Maes F, Nuttin B et al. Relationship between multiple sclerosis intention tremor severity and lesion load in the brainstem. Neuroreport 16(12), 1379-1382 (2005).
21. Vita G, Fazio MC, Milone S, Blandino A, Salvi L, Messina C. Cardiovascular autonomic dysfunction in multiple sclerosis is likely related to brainstem lesions. J. Neurol. Sci. 120(1), 82-86 (1993).
22. Juric S, Mišmaš A, Mihic N, Barac AM, Habek M. Newly onset sinus bradycardia in the context of multiple sclerosis relapse. Intern. Med. 51(9), 1121-1124 (2012).
23. Hengstman GJ, Kusters B. Sudden cardiac death in multiple sclerosis caused by active demyelination of the medulla oblongata. Mult. Scler. 17(9), 1146-1148 (2011).
24. Tippmann-Peikert M, Boeve BF, Keegan BM. REM sleep behavior disorder initiated by acute brainstem multiple sclerosis. Neurology 66(8), 1277-1279 (2006).
25. Braley TJ, Segal BM, Chervin RD. Sleep-disordered breathing in multiple sclerosis. Neurology 79(9), 929-936 (2012).
26. Tortorella P, Rocca MA, Colombo B, Annovazzi P, Comi G, Filippi M. Assessment of MRI abnormalities of the brainstem from patients with migraine and multiple sclerosis. J. Neurol. Sci. 244(1-2), 137-141 (2006).
27. Blanco Y, Compta Y, Graus F, Saiz A. Midbrain lesions and paroxysmal dysarthria in multiple sclerosis. Mult. Scler. 14(5), 694-697 (2008).
28. Damasceno A, Von Glehn F, Brandão CO, Damasceno BP, Cendes F. Prognostic indicators for long-term disability in multiple sclerosis patients. J. Neurol. Sci. 324(1-2), 29-33 (2013).
29. Poser CM, Paty DW, Scheinberg L et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann. Neurol. 13(3), 227-231 (1983).
30. McDonald WI, Compston A, Edan G et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann. Neurol. 50(1), 121-127 (2001).
31. Polman CH, Reingold SC, Edan G et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the 'McDonald Criteria'. Ann. Neurol. 58(6), 840-846 (2005).
32. Swanton JK, Fernando K, Dalton CM et al. Modification of MRI criteria for multiple sclerosis in patients with clinically isolated syndromes. J. Neurol. Neurosurg. Psychiatr. 77(7), 830-833 (2006).
33. Polman CH, Reingold SC, Banwell B et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann. Neurol. 69(2), 292-302 (2011).
34. Rovira A, Swanton J, Tintoré M et al. A single, early magnetic resonance imaging study in the diagnosis of multiple sclerosis. Arch. Neurol. 66(5), 587-592 (2009).
35. Montalban X, Tintoré M, Swanton J et al. MRI criteria for MS in patients with clinically isolated syndromes. Neurology 74(5), 427-434 (2010).
36. Gass A, Filippi M, Grossman RI. The contribution of MRI in the differential diagnosis of posterior fossa damage. J. Neurol. Sci. 172(Suppl. 1), S43-S49 (2000).
37. Yousry TA, Grossman RI, Filippi M. Assessment of posterior fossa damage in MS using MRI. J. Neurol. Sci. 172(Suppl. 1), S50-S53 (2000).
38. Wattjes MP, Lutterbey GG, Gieseke J et al. Double inversion recovery brain imaging at 3T: diagnostic value in the detection of multiple sclerosis lesions. AJNR. Am. J. Neuroradiol. 28(1), 54-59 (2007).
39. Wybrecht D, Reuter F, Zaaraoui W et al. Voxelwise analysis of conventional magnetic resonance imaging to predict future disability in early relapsing-remitting multiple sclerosis. Mult. Scler. 18(11), 1585-1591 (2012).
40. Archibald CJ, Wei X, Scott JN et al. Posterior fossa lesion volume and slowed information processing in multiple sclerosis. Brain 127(Pt 7), 1526-1534 (2004).
41. McDonald WI, Miller DH, Barnes D. The pathological evolution of multiple sclerosis. Neuropathol. Appl. Neurobiol. 18(4), 319-334 (1992).
42. Iannucci G, Minicucci L, Rodegher M, Sormani MP, Comi G, Filippi M. Correlations between clinical and MRI involvement in multiple sclerosis: assessment using T(1), T(2) and MT histograms. J. Neurol. Sci. 171(2), 121-129 (1999).
43. Losseff NA, Webb SL, O'Riordan JI et al. Spinal cord atrophy and disability in multiple sclerosis. A new reproducible and sensitive MRI method with potential to monitor disease progression. Brain 119(Pt 3), 701-708 (1996).
44. Edwards SG, Gong QY, Liu C et al. Infratentorial atrophy on magnetic resonance imaging and disability in multiple sclerosis. Brain 122(Pt 2), 291-301 (1999).
45. Liptak Z, Berger AM, Sampat MP et al. Medulla oblongata volume: a biomarker of spinal cord damage and disability in multiple sclerosis. AJNR. Am. J. Neuroradiol. 29(8), 1465-1470 (2008).
46. Barkhof F. The clinico-radiological paradox in multiple sclerosis revisited. Curr. Opin. Neurol. 15(3), 239-245 (2002).
47. Ceccarelli A, Rocca MA, Falini A et al. Normal-appearing white and grey matter damage in MS. A volumetric and diffusion tensor MRI study at 3.0 Tesla. J. Neurol. 254(4), 513-518 (2007).
48. Shiee N, Bazin PL, Zackowski KM et al. Revisiting brain atrophy and its relationship to disability in multiple sclerosis. PLoS ONE 7(5), e37049 (2012).
49. Comi G, Martinelli V, Locatelli T, Leocani L, Medaglini S. Neurophysiological and cognitive markers of disease evolution in multiple sclerosis. Mult. Scler. 4(3), 260-265 (1998).
50. McDonald WI, Sears TA. The effects of experimental demyelination on conduction in the central nervous system. Brain 93(3), 583-598 (1970).
51. Comi G, Filippi M, Martinelli V et al. Brain stem magnetic resonance imaging and evoked potential studies of symptomatic multiple sclerosis patients. Eur. Neurol. 33(3), 232-237 (1993).
52. Soustiel JF, Hafner H, Chistyakov AV et al. Brain-stem trigeminal and auditory evoked potentials in multiple sclerosis: physiological insights. Electroencephalogr. Clin. Neurophysiol. 100(2), 152-157 (1996).
53. O'Connor P, Marchetti P, Lee L, Perera M. Evoked potential abnormality scores are a useful measure of disease burden in relapsing-remitting multiple sclerosis. Ann. Neurol. 44(3), 404-407 (1998).
54. Jung P, Beyerle A, Ziemann U. Multimodal evoked potentials measure and predict disability progression in early relapsing-remitting multiple sclerosis. Mult. Scler. 14(4), 553-556 (2008).
55. Leocani L, Rovaris M, Boneschi FM et al. Multimodal evoked potentials to assess the evolution of multiple sclerosis: a longitudinal study. J. Neurol. Neurosurg. Psychiatr. 77(9), 1030-1035 (2006).
56. Invernizzi P, Bertolasi L, Bianchi MR, Turatti M, Gajofatto A, Benedetti MD. Prognostic value of multimodal evoked potentials in multiple sclerosis: the EP score. J. Neurol. 258(11), 1933-1939 (2011).
57. Pelayo R, Montalban X, Minoves T et al. Do multimodal evoked potentials add information to MRI in clinically isolated syndromes? Mult. Scler. 16(1), 55-61 (2010).
58. Matas CG, Matas SL, Oliveira CR, Gonçalves IC. Auditory evoked potentials and multiple sclerosis. Arq. Neuropsiquiatr. 68(4), 528-534 (2010).
59. Japaridze G, Shakarishvili R, Kevanishvili Z. Auditory brainstem, middle-latency, and slow cortical responses in multiple sclerosis. Acta Neurol. Scand. 106(1), 47-53 (2002).
60. Ko KF. The role of evoked potential and MR imaging in assessing multiple sclerosis: a comparative study. Singapore Med. J. 51(9), 716-720 (2010).
61. Rosengren SM, Welgampola MS, Colebatch JG. Vestibular evoked myogenic potentials: past, present and future. Clin. Neurophysiol. 121(5), 636-651 (2010).
62. Curthoys IS, Iwasaki S, Chihara Y, Ushio M, McGarvie LA, Burgess AM. The ocular vestibular-evoked myogenic potential to air-conducted sound; probable superior vestibular nerve origin. Clin. Neurophysiol. 122(3), 611-616 (2011).
63. Jacobson GP, McCaslin DL, Piker EG, Gruenwald J, Grantham SL, Tegel L. Patterns of abnormality in cVEMP, oVEMP, and caloric tests may provide topological information about vestibular impairment. J. Am. Acad. Audiol. 22(9), 601-611 (2011).
64. Murofushi T, Nakahara H, Yoshimura E, Tsuda Y. Association of air-conducted sound oVEMP findings with cVEMP and caloric test findings in patients with unilateral peripheral vestibular disorders. Acta Otolaryngol. 131(9), 945-950 (2011).
65. Nguyen KD, Welgampola MS, Carey JP. Test-retest reliability and age-related characteristics of the ocular and cervical vestibular evoked myogenic potential tests. Otol. Neurotol. 31(5), 793-802 (2010).
66. Chou CH, Wang SJ, Young YH. Feasibility of the simultaneous ocular and cervical vestibular-evoked myogenic potentials in unilateral vestibular hypofunction. Clin. Neurophysiol. 120(9), 1699-1705 (2009).
67. Alpini D, Pugnetti L, Caputo D, Cesarani A. Vestibular evoked myogenic potentials in multiple sclerosis: a comparison between onset and definite cases. Int. Tinnitus J. 11(1), 48-51 (2005).
68. Versino M, Colnaghi S, Callieco R, Bergamaschi R, Romani A, Cosi V. Vestibular evoked myogenic potentials in multiple sclerosis patients. Clin. Neurophysiol. 113(9), 1464-1469 (2002).
69. Eleftheriadou A, Deftereos SN, Zarikas V et al. The diagnostic value of earlier and later components of Vestibular Evoked Myogenic Potentials (VEMP) in multiple sclerosis. J. Vestib. Res. 19(1-2), 59-66 (2009).
70. Bandini F, Beronio A, Ghiglione E, Solaro C, Parodi RC, Mazzella L. The diagnostic value of vestibular evoked myogenic potentials in multiple sclerosis. J. Neurol. 251(5), 617-621 (2004).
71. Patkó T, Simó M, Arányi Z. Vestibular click-evoked myogenic potentials: sensitivity and factors determining abnormality in patients with multiple sclerosis. Mult. Scler. 13(2), 193-198 (2007).
72. Sartucci F, Logi F. Vestibular-evoked myogenic potentials: a method to assess vestibulo-spinal conduction in multiple sclerosis patients. Brain Res. Bull. 59(1), 59-63 (2002).
73. Shimizu K, Murofushi T, Sakurai M, Halmagyi M. Vestibular evoked myogenic potentials in multiple sclerosis. J. Neurol. Neurosurg. Psychiatr. 69(2), 276-277 (2000).
74. Gabelic T, Krbot M, Sefer AB, Isgum V, Adamec I, Habek M. Ocular and cervical vestibular evoked myogenic potentials in patients with multiple sclerosis. J. Clin. Neurophysiol. 30(1), 86-91 (2013).
75. Gazioglu S, Boz C. Ocular and cervical vestibular evoked myogenic potentials in multiple sclerosis patients. Clin. Neurophysiol. 123(9), 1872-1879 (2012).
76. Adamec I, Gabelic T, Krbot M, Ozretic D, Milivojevic I, Habek M. Primary position upbeat nystagmus. J. Clin. Neurosci. 19(1), 161-162 (2012).
77. Van Loven K, Jacobs R, Van Hees J, Van Huffel S, van Steenberghe D. Trigeminal somatosensory evoked potentials in humans. Electromyogr. Clin. Neurophysiol. 41(6), 357-375 (2001).
78. Cruccu G, Aminoff MJ, Curio G et al. Recommendations for the clinical use of somatosensory-evoked potentials. Clin. Neurophysiol. 119(8), 1705-1719 (2008).
79. Boucher Y, Simons CT, Faurion A, Azérad J, Carstens E. Trigeminal modulation of gustatory neurons in the nucleus of the solitary tract. Brain Res. 973(2), 265-274 (2003).
80. Sakamoto K, Nakata H, Kakigi R. Somatotopic representation of the tongue in human secondary somatosensory cortex. Clin. Neurophysiol. 119(9), 2125-2134 (2008).
81. Bergamaschi R, Romani A, Versino M et al. Usefulness of trigeminal somatosensory evoked potentials to detect subclinical trigeminal impairment in multiple sclerosis patients. Acta Neurol. Scand. 89(6), 412-414 (1994).
82. Guterman H, Nehmadi Y, Chistyakov A, Soustiel J, Hafner H, Feinsod M. Classification of brain-stem trigeminal evoked potentials in multiple sclerosis, minor head injuries and post-concussion syndrome pathologies by similarity measurements. Int. J. Med. Inform. 60(3), 303-318 (2000).
83. Altenmüller E, Cornelius CP, Buettner UW. Somatosensory evoked potentials following tongue stimulation in normal subjects and patients with lesions of the afferent trigeminal system. Electroencephalogr. Clin. Neurophysiol. 77(6), 403-415 (1990).
84. Gabelic T, Krbot Skoric M, Adamec I, Mayer D, Habek M. Tongue somatosensory evoked potentials: evaluation of the afferent trigeminal pathway in patients with early multiple sclerosis. Clin. EEG Neurosci. (2013) (In Press).
85. Gunal DI, Afsar N, Tanridag T, Aktan S. Autonomic dysfunction in multiple sclerosis: correlation with disease-related parameters. Eur. Neurol. 48(1), 1-5 (2002).
86. Stenager E, Stenager EN, Jensen K. Sexual aspects of multiple sclerosis. Semin. Neurol. 12(2), 120-124 (1992).
87. Kale N, Magana S, Agaoglu J, Tanik O. Assessment of autonomic nervous system dysfunction in multiple sclerosis and association with clinical disability. Neurol. Int. 1(1), e5 (2009).
88. Acevedo AR, Nava C, Arriada N, Violante A, Corona T. Cardiovascular dysfunction in multiple sclerosis. Acta Neurol. Scand. 101(2), 85-88 (2000).
89. Nasseri K, TenVoorde BJ, Adèr HJ, Uitdehaag BM, Polman CH. Longitudinal follow-up of cardiovascular reflex tests in multiple sclerosis. J. Neurol. Sci. 155(1), 50-54 (1998).
90. Kanjwal K, Karabin B, Kanjwal Y, Grubb BP. Autonomic dysfunction presenting as postural orthostatic tachycardia syndrome in patients with multiple sclerosis. Int. J. Med. Sci. 7, 62-67 (2010).
91. Adamec I, Bach I, Barušic AK, Mišmaš A, Habek M. Assessment of prevalence and pathological response to orthostatic provocation in patients with multiple sclerosis. J. Neurol. Sci. 324(1-2), 80-83 (2013).
92. Freeman R, Wieling W, Axelrod FB et al. Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Clin. Auton. Res. 21(2), 69-72 (2011).
93. Flachenecker P, Wolf A, Krauser M, Hartung HP, Reiners K. Cardiovascular autonomic dysfunction in multiple sclerosis: correlation with orthostatic intolerance. J. Neurol. 246(7), 578-586 (1999).
94. Adamec I, Ozretic D, Habek M. Autonomic dysfunction in multiple sclerosis presenting with postural orthostatic tachycardia. Acta Neurol. Belg. doi:10.1007/s13760-012-0158-2 (2013) (Epub ahead of print).
95. Adamec I, Lovri? M, Žaper D et al. Postural orthostatic tachycardia syndrome associated with multiple sclerosis. Auton. Neurosci. 173(1-2), 65-68 (2013).
96. Carew S, Connor MO, Cooke J et al. A review of postural orthostatic tachycardia syndrome. Europace 11(1), 18-25 (2009).
97. Sanya EO, Tutaj M, Brown CM, Goel N, Neundörfer B, Hilz MJ. Abnormal heart rate and blood pressure responses to baroreflex stimulation in multiple sclerosis patients. Clin. Auton. Res. 15(3), 213-218 (2005).
98. Yamanaka A, Muraki Y, Ichiki K et al. Orexin neurons are directly and indirectly regulated by catecholamines in a complex manner. J. Neurophysiol. 96(1), 284-298 (2006).
99. Merlino G, Fratticci L, Lenchig C et al. Prevalence of 'poor sleep' among patients with multiple sclerosis: an independent predictor of mental and physical status. Sleep Med. 10(1), 26-34 (2009).
100. Bamer AM, Johnson KL, Amtmann D, Kraft GH. Prevalence of sleep problems in individuals with multiple sclerosis. Mult. Scler. 14(8), 1127-1130 (2008).
101. Tachibana N, Howard RS, Hirsch NP, Miller DH, Moseley IF, Fish D. Sleep problems in multiple sclerosis. Eur. Neurol. 34(6), 320-323 (1994).
102. Lobentanz IS, Asenbaum S, Vass K et al. Factors influencing quality of life in multiple sclerosis patients: disability, depressive mood, fatigue and sleep quality. Acta Neurol. Scand. 110(1), 6-13 (2004).
103. Ferini-Strambi L, Filippi M, Martinelli V et al. Nocturnal sleep study in multiple sclerosis: correlations with clinical and brain magnetic resonance imaging findings. J. Neurol. Sci. 125(2), 194-197 (1994).
104. Nightingale S, Orgill JC, Ebrahim IO, de Lacy SF, Agrawal S, Williams AJ. The association between narcolepsy and REM behavior disorder (RBD). Sleep Med. 6(3), 253-258 (2005).